Vi Partners, based in Altendorf, celebrates 25 years of venture investing with the first close of its €161 million (CHF 150 million) fund. The fund was supported by the firm’s existing investors.
- Founded in 2001, Vi Partners has invested CHF 400 million in 72 technology and healthcare startups over 25 years. Its funds are supported by Swiss companies and institutions including ETH Zurich, ABB, Bühler, UBS, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva, and ZKB, as well as other institutional and private investors.
- The new fund will target Series A and early-stage investments in technology and healthcare. In technology, Vi Partners invests in companies developing critical software and data-driven platforms across enterprise, AI, fintech, and industrial applications.
- In healthcare, it supports startups addressing significant clinical and healthcare system needs in biotech, medtech, and digital health. The firm draws on its experience as an early investor in companies such as AMAL Therapeutics, Kuros Biosciences, Araris Biotech, and Oculis in healthcare, and Nexthink, SumUp, and Unique in technology.
“Over the past 25 years, we have consistently focused on identifying and supporting teams with strong scientific and technological foundations with the ambition to build outstanding companies. This new fund allows us to continue applying a disciplined, long-term investment approach, grounded in deep sector expertise and close collaboration with entrepreneurs," claims Diego Braguglia, Managing Partner at Vi Partners.
- After this first close, Vi Partners will start investing the fund’s capital, with additional closings planned later in the year.
“With this fund, we are entering the next phase of our investment activity and look forward to partnering with founders building category-defining companies out of Switzerland and Europe. Our role is to be a committed, hands-on partner from the early stages onward, combining capital with experience, network, and long-term support," Managing Partner at Vi Partners, Olivier Laplace, commented.
